Fate Therapeutics, Inc. (FATE)
NASDAQ·Healthcare·Biotechnology
$2.61
+4.60%
Mkt Cap $285.57M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (21 analysts)
$4.00
Range $4.00 – $4.00
Implied Upside
+53.3%
Consensus $4.00 vs current $2.61
NASDAQ·Healthcare·Biotechnology
$2.61
+4.60%
Mkt Cap $285.57M
Buy
2
Hold
0
Sell
0
Price Target (21 analysts)
$4.00
Range $4.00 – $4.00
+53.3%
Consensus $4.00 vs current $2.61